AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 277 filers reported holding AVANOS MED INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,903 | -42.4% | 64 | -47.5% | 0.00% | – |
| Q4 2022 | $3,301 | -87.8% | 122 | -83.3% | 0.00% | -100.0% |
| Q2 2021 | $27,000 | -87.3% | 730 | -85.0% | 0.00% | -87.5% |
| Q1 2021 | $212,000 | -10.5% | 4,852 | -6.0% | 0.01% | -20.0% |
| Q4 2020 | $237,000 | +34.7% | 5,162 | -3.0% | 0.01% | +25.0% |
| Q3 2020 | $176,000 | -18.1% | 5,323 | -27.4% | 0.01% | -33.3% |
| Q2 2020 | $215,000 | -3.2% | 7,335 | -10.9% | 0.01% | -20.0% |
| Q1 2020 | $222,000 | +39.6% | 8,232 | +74.1% | 0.02% | +87.5% |
| Q4 2019 | $159,000 | +200.0% | 4,729 | +293.1% | 0.01% | +166.7% |
| Q3 2019 | $53,000 | 0.0% | 1,203 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $53,000 | +43.2% | 1,203 | +39.7% | 0.00% | 0.0% |
| Q1 2019 | $37,000 | -9.8% | 861 | -7.0% | 0.00% | -25.0% |
| Q4 2018 | $41,000 | -40.6% | 926 | -7.5% | 0.00% | -20.0% |
| Q3 2018 | $69,000 | -22.5% | 1,001 | -35.6% | 0.01% | -28.6% |
| Q2 2018 | $89,000 | – | 1,554 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,482,743 | $113,908,000 | 6.40% |
| RGM Capital, LLC | 1,984,455 | $91,047,000 | 3.97% |
| Cove Street Capital, LLC | 204,438 | $9,380,000 | 1.66% |
| Millrace Asset Group, Inc. | 41,200 | $1,890,000 | 1.32% |
| Phocas Financial Corp. | 142,037 | $6,516,000 | 1.00% |
| Champlain Investment Partners, LLC | 3,470,935 | $159,246,000 | 0.91% |
| HEARTLAND ADVISORS INC | 231,533 | $10,623,000 | 0.76% |
| CONFLUENCE INVESTMENT MANAGEMENT LLC | 481,042 | $22,070,000 | 0.33% |
| Wakefield Asset Management LLLP | 14,653 | $672,000 | 0.28% |
| S.A. Mason LLC | 6,527 | $299,000 | 0.25% |